Release date: 2006-12-25
Experts in Nanjing have made a breakthrough in blood filtration technology, developing a new "blood lipid filter" that has captured national attention. Scientists at the Nanjing Red Cross Blood Center recently introduced an innovative device with independent intellectual property rights, which successfully passed a national scientific and technological achievement evaluation. This development marks a significant advancement in the field of lipid management and cardiovascular health.
The four-year research project has led to a groundbreaking solution that effectively removes harmful low-density lipoproteins (LDL) and cholesterol from the bloodstream while preserving high-density lipoproteins (HDL), which are known to be beneficial for heart health. Compared to similar technologies available in Japan and Germany, this new filter not only performs better but also comes at a fraction of the cost—approximately one-tenth of imported alternatives. This cost efficiency could greatly enhance the accessibility of treatment for patients suffering from hyperlipidemia and high cholesterol.
This innovation is expected to play a key role in improving the utilization of blood resources and reducing the financial burden on patients. As more countries look for affordable and effective medical solutions, the Nanjing team’s work stands out as a promising step forward in global healthcare technology. The success of this project highlights the growing influence of Chinese research in the medical field and its potential to impact patient care worldwide.
Amino Acid Chelate, Potassium Amino Acid Chelate,Magnesium Amino Acid Chelate Selenium Amino Acid Chelate, Iron Amino Acid Chelate, Zinc Amino Acid Chelate,Manganese Amino Acid Chelate
Xi'an Hersoncare Bio-Tech Co., Ltd , https://www.hersoncarebio.com